These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12047025)

  • 1. Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines.
    Finnerty M; Altmansberger R; Bopp J; Carpinello S; Docherty JP; Fisher W; Jensen P; Krishnan P; Mittleman M; Olfson M; Tricarico J; White T; Felton C
    Schizophr Bull; 2002; 28(1):85-94. PubMed ID: 12047025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia treatment guidelines in the United States.
    Moore TA
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):40-9. PubMed ID: 21459738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a clinical practice guideline for schizophrenia in a specialist mental health center: an observational study.
    Fischler I; Riahi S; Stuckey MI; Klassen PE
    BMC Health Serv Res; 2016 Aug; 16(a):372. PubMed ID: 27514778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outpatient treatment in schizophrenia: effects of computerized guideline implementation--results of a multicenter-study within the German research network on schizophrenia.
    Janssen B; Ludwig S; Eustermann H; Menke R; Haerter M; Berger M; Adam G; Seemann U; Kissling W; Gaebel W
    Eur Arch Psychiatry Clin Neurosci; 2010 Feb; 260(1):51-7. PubMed ID: 19876665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing variation in the pharmacologic treatment of schizophrenia: defining acceptable standards of treatment.
    Constantine RJ
    Curr Psychiatry Rep; 2007 Aug; 9(4):319-24. PubMed ID: 17880864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying clinical relevance in the treatment of schizophrenia.
    Correll CU; Kishimoto T; Nielsen J; Kane JM
    Clin Ther; 2011 Dec; 33(12):B16-39. PubMed ID: 22177377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing treatment guidelines.
    Miller AL
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):15-6. PubMed ID: 21459734
    [No Abstract]   [Full Text] [Related]  

  • 8. Adherence to guidelines and treatment compliance in the Chilean national program for first-episode schizophrenia.
    Markkula N; Alvarado R; Minoletti A
    Psychiatr Serv; 2011 Dec; 62(12):1463-9. PubMed ID: 22193794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines based on decision support software. Quality management in neurological outpatient schizophrenia treatment].
    Janssen B; Menke R; Pourhassan F; Gessner-Ozokyay D; Peters R; Gaebel W
    Nervenarzt; 2006 May; 77(5):567-75. PubMed ID: 15765230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching antipsychotic medications to reduce adverse event burden in schizophrenia: establishing evidence-based practice.
    Newcomer JW; Weiden PJ; Buchanan RW
    J Clin Psychiatry; 2013 Nov; 74(11):1108-20. PubMed ID: 24330898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of electronic medical record data for quality improvement in schizophrenia treatment.
    Owen RR; Thrush CR; Cannon D; Sloan KL; Curran G; Hudson T; Austen M; Ritchie M
    J Am Med Inform Assoc; 2004; 11(5):351-7. PubMed ID: 15187073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to manage in current treatment of schizophrenic patients.
    Loga S
    Psychiatr Danub; 2007 Dec; 19(4):359-61. PubMed ID: 18000489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotherapy for schizophrenia].
    Fleischhacker WW; Hummer W
    Nervenarzt; 2006 Nov; 77 Suppl 2():S77-97; S98. PubMed ID: 17082927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia].
    Delessert D; Pomini V; Grasset F; Baumann P
    Encephale; 2008 Jan; 34(1):93-100. PubMed ID: 18514156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 18. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.
    Leslie DL; Rosenheck RA
    J Ment Health Policy Econ; 2003 Sep; 6(3):113-21. PubMed ID: 14646004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current concepts of pharmacological treatment in schizophrenia].
    Jarema M
    Psychiatr Pol; 2002; 36(6):857-68. PubMed ID: 12725017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.